Thrombocytopenia in pregnancy

Platelets, Second Edition

Volumn , Issue , 2006, Pages 925-942

  McCrae, Keith R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34648842973     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369367-9/50813-2     Document Type: Chapter

References (189)

1. K.R. McCrae, J.B. Bussel, P.M. Mannucci, et al. (2001) Platelets: An update on diagnosis and management of thrombocytopenic disorders. Hematology (Am Soc Hematol Educ Program) 282-305.
2. K.R. McCrae and D.B. Cines (1997) Thrombotic microangiopathy during pregnancy. Sem Hematol 34 48-158.
3. J.R. McMinn and J.N. George (2001) Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin Apheresis 16 202-209.
4. M.A. Crowther, R.F. Burrows, J. Ginsberg, et al. (1996) Thrombocytopenia in pregnancy: Diagnosis, pathogenesis and managment. Blood Rev 10 8-18.
5. J.G. Kelton (2002) Idiopathic thrombocytopenic purpura complicating pregnancy. Blood Rev 16 43-46.
6. D. Provan, A. Newland, D. Norfolk, et al. (2003) Guidelines for the investigation and managment of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120 574-596.
7. N. Shehata, R.F. Burrows and J.G. Kelton (1999) Gestational thrombocytopenia. Clin Obstet Gynecol 42 327-334.
8. R.F. Burrows and J.G. Kelton (1988) Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med 319 142-145.
9. K.R. McCrae, P. Samuels and A.D. Schreiber (1992) Pregnancy-associated thrombocytopenia: Pathogenesis and management. Blood 80 2697-2714.
10. R.F. Burrows and J.G. Kelton (1990) Thrombocytopenia at delivery: A prospective survey of 6715 deliveries. Am J Obstet Gynecol 162 731-734.
11. J.H. Matthews, S. Benjamin, D.S. Gill, et al. (1990) Pregnancy-associated thrombocytopenia: Definition, incidence and natural history. Acta Haemat 84 24-29.
12. F. Boehlen, H. Hohlfeld, P. Extermann, et al. (2000) Platelet count at term pregnancy: A reappraisal of the threshold. Obstet Gynecol 95 29-33.
13. S. Sainio, R. Kekomäki, S. Riikonon, et al. (2000) Maternal thrombocytopenia at term: A population-based study. Acta Obstet Gynecol Scand 79 744-749.
14. R.F. Burrows and J.G. Kelton (1993) Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 329 1463-1466.
15. E.A. Letsky and M. Greaves (1996) Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Br J Haematol 95 21-36.
16. M. Ruggeri, C. Schiavotto, G. Castaman, et al. (1997) Gestational thrombocytopenia: A prospective study. Haematologica 82 341-342.
17. D.B. Cines and V.S. Blanchette (2002) Immune thrombocytopenic purpura. N Engl J Med 346 13-995.
18. D. Provan and A. Newland (2003) Idiopathic thrombocytopenic purpura in adults. J Ped Hematol Oncol 25 S34-S38. (suppl 1
19. W.J. Harrington, V. Minnich, J.W. Hollingsworth, et al. (1951) Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 38 1-8.
20. D.B. Cines and R. McMillan (2005) Management of adult idiopathic thrombocytopenic purpura. Ann Rev Med 56 425-442.
21. M. Chang, P.A. Nakagawa, S.A. Williams, et al. (2003) Immune thrombocytopenic purpura (ITP) plasma and puri-fied ITP monoclonal autoantibodies inhibit megakaryocytopoiesis. in vitro. Blood 102 887-895.
22. R. McMillan, L. Wang, A. Tomer, et al. (2004) Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 103 1364-1369.
23. K.K. Gill and J.G. Kelton (2000) Management of idiopathic thrombocytopenic purpura in pregnancy. Sem Hematol 37 275-283.
24. R. Karim and R.A. Sacher (2004) Thrombocytopenia in pregnancy. Curr Hematol Rep 3 128-133.
25. C.S.H.G.H.T.F. British Committee for Standards in Haematology General Haematology Task Force. (2003) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120 574-596.
26. K.E. Webert, R. Mittal, C. Siguoin, et al. (2003) A retrospective 11-year analysis of obstetric patients with idiopathic thromobocytopenic purpura. Blood 102 4306-4311.
27. P. Samuels, E.K. Main, A. Tomaski, et al. (1987) Abnormalities in platelet antiglobulin tests in preeclamptic mothers and their neonates. Am J Obstet Gynecol 107 109-113.
28. K. Fujimura, Y. Harada, T. Fujimoto, et al. (2002) Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Haematol 75 426-433.
29. J.N. George, S.H. Woolf, G.E. Raskob, et al. (1996) Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 88 3-40.
30. T. Moeller-Bertram, K.M. Kuczkowski and J.L. Benumof (2004) Uneventful epidural labor analgesia in a parturient with immune thrombocytopenic purpura and platelet count of 26,000/mm3 which was unknown preoperatively. J Clin Anesthesiol 16 51-53.
31. M. Michel, M.V. Novoa and J.B. Bussel (2003) Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy. Br J Haematol 123 142-146.
32. M.J. Kahn and K.R. McCrae (2004) Splenectomy in immune thrombocytopenic purpura: Recent controversies and long-term outcomes. Curr Hematol Rep 3 317-323.
33. P. Gottlieb, O. Axelsson, O. Bakos, et al. (1999) Splenectomy during pregnancy: An option in the treatment of autoimmune thrombocytopenic purpura. Br J Obstet Gynaecol 106 373-375.
34. R. Stasi, A. Pagano, E. Stipa, et al. (2001) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 98 952-957.
35. E. Kimby, E. Sverrisdotter and G. Elinder (2004) Safety of rituximab therapy during the first trimester of pregnancy: A case history. Eur J Haematol 72 292-295.
36. R.F. Burrows and J.G. Kelton (1993) Pregnancy in patients with idiopathic thrombocytopenic purpura: Assessing the risks for the infant at delivery. Obstet Gynecol Surv 48 781-788.
37. J.G. Kelton (2002) Idiopathic thrombocytopenic purpura complicating pregnancy. Blood Rev 16 43-46.
38. C. Godelieve, M.L. Christiaens, H.K. Nieuwenhuis, et al. (1997) Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura. Obstet Gynecol 90 546-552.
39. S.D. Payne, R. Resnik, T.R. Moore, et al. (1997) Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia. Am J Obstet Gynecol 177 149-155.
40. D. Peleg and S.K. Hunter (1999) Perinatal management of women with immune thrombocytopenic purpura: Survey of United States perinatologists. Am J Obstet Gynecol 180 645-650.
41. J. Zhang, S. Meikle and A. Trumble (2003) Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Preg 203-212.
42. K.Y. Lain and J.M. Roberts (2002) Contemporary concepts of the pathogenesis and management of preeclampsia. J Am Med Assoc 287 3183-3186.
43. K. Duckitt and D. Harrington (2005) Risk factors for preeclampsia at antenatal booking: Systemic review of controlled studies. Br Med J 330 595-601.
44. G.R.H.B.P.P. Working Group Report on High Blood Pressure in Pregnancy (2000) NIH Publication No. 00-3029 Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute
45. G. Pridjian and J.B. Puschett (2002) Preeclampsia. Part 1: Clinical and pathophysiological considerations. Obstet Gynecol Surv 57 598-618.
46. C.O.G. American College of Obstet Gynecol. (2002) ACOG practice bulletin: Diagnosis and management of preeclampsia in pregnancy. Obstet Gynecol 99 159-167.
47. N. Mahmoudi, S.W. Graves and C.G. Solomon (1999) Eclampsia: A 13-year experience at a United States tertiary care center. J Womens Health Gender Based Med 8 495-500.
48. M.S. Esplin, M.B. Fausett, A. Fraser, et al. (2001) Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 344 867-872.
49. J.L. Mills, M.A. Klebanoff, B.I. Graubard, et al. (1991) Barrier contraceptive methods and preeclampsia. J Am Med Assoc 265 70-73.
50. D.K. Li and S. Wi (2000) Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. Am J Epidemiol 151 57-62.
51. R. Skj˦rven, A.J. Wilcox and R.T. Lie (2002) The interval between pregnancies and the risk of preeclampsia. N Engl J Med 346 33-38.
52. P.Y. Robillard, G.A. Dekker and T.C. Hulsey (1999) Revisiting the epidemiological standard of preeclampsia: Primigravidity of primipaternity. Eur J Obstet Gynecol Repro Biol 84 37-41.
53. J.M. Roberts and D.W. Cooper (2001) Pathogenesis and genetics of preeclampsia. Lancet 357 53-56.
54. G. Pridjian and J.B. Puschett (2002) Preeclampsia. Part 2: Experimental and genetic considerations. Obstet Gynecol Surv 57 619-640.
55. consortium. GOPEC (2005) Disentangling fetal and maternal susceptibility for pre-eclampsia: A British multicenter candidate gene study. Am J Human Genet 77 127-131.
56. A.F. Saftlas, H. Beydoun and E. Triche (2005) Immunogenetic determinants of preeclampsia and related pregnancy disorders: A systematic review. Obstet Gynecol 106 162-172.
57. O.M. Alsulyman, M.A. Castro, E. Zuckerman, et al. (1996) Preeclampsia and liver infarction in early pregnancy associated with the antiphospholipid syndrome. Obstet Gynecol 88 644-646.
58. W.A. Wilson, A.E. Gharavi, T. Koike, et al. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arth Rheum 42 1309-1311.
59. H.A. Shehata, C. Nelson-Piercy and M.A. Khamashta (2001) Management of pregnancy in the antiphospholipid syndrome. Rheum Dis Clin NA 27 643-649.
60. G.A. Dekker, J.I. deVries, P.M. Doelitzsch, et al. (1995) Underlying disorders associated with severe, early onset preeclampsia. Am J Obstet Gynecol 173 1042-1048.
61. D.S. Dizon-Townson, L.M. Nelson, K. Easton, et al. (1996) The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 175 902-905.
62. E. Grandone, M. Margaglione, D. Colaizzo, et al. (1997) Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 77 1052-1054.
63. M.J. Kupferminc, A. Eldor, M. Steinman, et al. (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999 340-349.
64. A.V. D'Elia, L. Driul, R. Giacomello, et al. (2002) Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia. Gynecol Obstet Invest 53 84-87.
65. Anonymous. Is there an increased maternal-infant prevalence of factor V Leiden in association with severe preeclampsia? Br J Obstet Gynaecol 109 191-196.
66. J.C. Livingston, J.R. Barton, V. Park, et al. (2001) Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol 185 153-157.
67. Z. Alfirevic, D. Roberts and V. Martlew (2002) How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Repro Biol 101 6-14.
68. H. Stanley-Christian, A. Ghidini, R. Sacher, et al. (2005) Fetal genotype for specific thrombophilias is not associated with severe preeclampsia. J Soc Gynecol Invest 12 198-201.
69. C.P.J. Witsenburg, F.R. Rosendall, J.M. Middeldorp, et al. (2005) Factor VIII levels and the risk of preeclampsia, HELLP syndrome, pregnancy related hypertension and severe intrauterine growth retardation. Thromb Res 115 382-392.
70. D. Goldman-Wohl and S. Yagel (2002) Regulation of trophoblast invasion: From normal implantation to preeclampsia. Mol Cell Endocrinol 187 233-238.
71. I.O. Brosens (1988) The utero-placental vessels at term —the distribution and extent of physiological changes. Troph Res 3 61-67.
72. T.Y. Khong, F. De Wolf, W.B. Robertson, et al. (1987) Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small for gestational age infants. Am J Obstet Gynecol 157 360-363.
73. Y. Zhou, C.H. Damsky, K. Chiu, et al. (1993) Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 91 950-960.
74. Y. Zhou, C.H. Damsky and S.J. Fisher (1997) Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. J Clin Invest 99 2152-2164.
75. Y. Zhou, S.J. Fisher, M. Janatpour, et al. (1997) Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 99 2139-2151.
76. C.H. Graham and K.R. McCrae (1996) Expression of gelatinase and plasminogen activator activity by trophoblast cells isolated from the placentae of normal and preeclamptic women. Am J Obstet Gynecol 175 555-562.
77. V. Tsatsiris, F. Goffinm, C. Munuat, et al. (2003) Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: Pathophysiological consequences. J Clin Endo Metab 88 5555-5563.
78. R.J. Levine, S.E. Maynard, C. Qian, et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 672-683.
79. N. Soleymanlou, I. Jurisica, O. Nevo, et al. (2005) Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab 90 4299-4308.
80. R.N. Taylor, M. Varma, N.N.H. Teng, et al. (1990) Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 71 1675-1677.
81. A. Nova, B.M. Sibai, J.R. Barton, et al. (1991) Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 165 724-727.
82. G.A. Dekker, A.A. Kraayenbrink, G.G. Zeeman, et al. (1991) Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe preeclampsia. Eur J Obstet Gynecol Repro Biol 40 215-220.
83. L. Myatt and X. Cui (2004) Oxidative stress in the placenta. Histochem Cell Biol 122 369-382.
84. K.R. McCrae (2003) Thrombocytopenia in pregnancy: Differential diagnosis, pathogenesis and management. Blood Rev 17 7-14.
85. K. deBoer, C.J.W. ten Cate J.W., A. Sturk, et al. (1989) Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 160 95-100.
86. B. Brenner, E. Zwang, M. Bronshtein, et al. (1989) Von Willebrand factor multimer patterns in pregnancy-induced hypertension. Thromb Haemost 62 715-717.
87. J.M. Thorp, G.C. White, J.L. Moake, et al. (1990) Von Willebrand factor multimeric levels and patterns in patients with severe preeclampsia. Obstet Gynecol 75 163-167.
88. C.J. Lockwood and J.H. Peters (1990) Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol 162 358-362.
89. C.W.G. Redman, L.J. Beilin, K.W.E. Denson, et al. (1977) Factor VIII consumption in pre-eclampsia. Lancet, ii 1249-1252.
90. W.M. Curtin and L. Weinstein (1999) A review of the HELLP syndrome. J Perinatol 19 138-143.
91. J.M. O'Brien and J.R. Barton (2005) Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol 48 460-477.
92. J.R. Barton and B.M. Sibai (2004) Diagnosis and management of hemolysis, elevated liver enzymes and low platelets syndrome. Clin Perinatol 31 807-833.
93. B.M. Sibai (1990) The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) : Much ado about nothing? Am J Obstet Gynecol 162 311-316.
94. J.N. Martin, P.G. Blake, S.L. Lowry, et al. (1990) Pregnancy complicated by preeclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet counts: How rapid is postpartum recovery. Obstet Gynecol 76 737-741.
95. W. Rath, A. Faridi and J.W. Dudenhausen (2000) HELLP syndrome. J Perinatal Med 28 249-260.
96. L.P. McMahon and J. Smith (1997) The HELLP syndrome at 16 weeks gestation: Possible association with the antiphospholipid syndrome. Aust NZJ Obstet Gynaecol 37 313-314.
97. K. Haram, J. Trovik, P.M. Sanset, et al. (2003) Severe syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP) in the 18th week of pregnancy associated with the antiphospholipid-antibody syndrome. Acta Obstet Gynecol Scand 82 679-680.
98. T.T.D. Li Thi Thoung D., N. Tieulie, N. Costedoat, et al. (2005) The HELLP syndrome in the antiphospholipid syndrome: Retrospective study of 16 cases in 15 women. Ann Rheum Dis 64 273-278.
99. K. Nagayama, N. Izumi, Y. Miyasaka, et al. (1997) Hemolysis, elevated liver enzymes, and low platelets syndrome associated with primary anti-phospholipid antibody syndrome. Intern Med 36 661-667.
100. E.F. Magann and J.R. Martin (1999) Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol 42 532-550.
101. B.M. Sibai (2004) Diagnosis, controversies and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103 981-991.
102. M.A. Murphy and M. Ayazifar (2005) Permanent visual defects secondary to the HELLP syndrome. J Neuro-Opthalmol 25 122-127.
103. B.K. Rinehart, D.A. Terrone, W.L. May, et al. (2001) Change in platelet count predicts eventual maternal outcome with syndrome of hemolysis, elevated liver enzymes and low platelet count. J Mat Fet Med 10 28-34.
104. J.N. Martin, P.G. Blake, K.G. Perry, et al. (1991) The natural history of HELLP syndrome: Patterns of disease progression and regression. Am J Obstet Gynecol 164 1500-1513.
105. A. Faridi, W. Heyl and W. Rath (2000) Preliminary results of the International HELLP-Multicenter-Study. Int J Gynaecol Obstet 69 279-280.
106. B.M. Sibai, M.M. Taslimi, A. El-Nazer, et al. (1986) Maternal-perinatal outome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 155 501-509.
107. M.L. Schwartz and W.E. Brenner (1978) The obfuscation of eclampsia by thrombotic thrombocytopenic purpura. Am J Obstet Gynecol 131 10-18.
108. K.H. Coppage and B.M. Sibai (2005) Treatment of hypertensive complications of pregnancy. Current Pharm Des 11 749-757.
109. W. Visser and H.C.S. Wallenburg (1995) Temporizing management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 102 111-117.
110. B. Hogg, J.C. Hauth, S.N. Caritis, et al. (1999) Safety of labor epidural anesthesia for women with severe hypertensive disease: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 181 1096-1101.
111. P.S. Barilleaux, J.N. Martin, C.K. Klauser, et al. (2005) Postpartum intravenous dexamethasone for severely preeclamptic patients without hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome: A randomized trial. Obstet Gynecol 105 843-848.
112. P.J. van Runnard Heimel, A. Franx, A.F.A.M. Schobben, et al. (2004) Corticosteroids, pregnancy, and HELLP syndrome: A review. Obstet Gynecol Surv 60 57-70.
113. C.H. Rose, B.D. Thigpen, J.A. Bofill, et al. (2004) Obstetric implications of antepartum corticosteroid therapy for HELLP syndrome. Obstet Gynecol 104 1011-1014.
114. J.M. O'Brien, D.A. Milligan and J.R. Barton (2000) Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 183 304-309.
115. J.N. Martin, K.G. Perry, P.G. Blake, et al. (1997) Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet Gynecol 177 1011-1017.
116. J.N. Martin Jr., J.C. Files, P.G. Blake, et al. (1990) Plasma exchange for preeclampsia. I. Postpartum use for persistently severe preeclampsia-eclampsia with HELLP syndrome. Am J Obstet Gynecol 162 126-137.
117. J.N. Martin Jr., J.C. Files, P.G. Blake, et al. (1995) Postpartum plasma exchange for atypical preeclampsiaeclampsia as HELLP (hemolysis, elevated liver enzymes and low platelets syndrome). Am J Obstet Gynecol 172 1107-1112.
118. B. Eser, M. Guven, A. Unal, et al. (2005) The role of plasma exchange in HELLP syndrome. Clin Applied Thromb/ Hemost 11 211-217.
119. C.G. CLASP Collaborative Group. (1994) CLASP: A randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 343 619-629.
120. J.M. Roberts, G. Pearson, J. Cutler, et al. (2003) Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension 41 437-445.
121. L.C. Chappell, P.T. Seed, A.L. Briley, et al. (1999) Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: A randomized trial. Lancet 354 810-816.
122. A. Rumbold and C.A. Crowther (2005) Vitamin E supplementation in pregnancy. Cochrane Database Sys Rev April 18.
123. D.P. Miller, J.A. Kaye, N. Ziyadeh, et al. (2004) Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Epidemiol 15 208-215.
124. T.J. Torok, R.C. Holman and T.L. Chorba (1995) Increasing mortality from thrombotic thrombocytopenic purpura in the United States —analysis of national mortality data 1968-1961. Am J Hematol 5084 90.
125. R.L. Ridolfi and W.R. Bell (1981) Thrombotic thrombocytopenia purpura: Report of 25 cases and a review of the literature. Medicine 60 413-428.
126. S.K. Vesely, J.N. George, B. Lämmle, et al. (2003) ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 102 60-68.
127. K.K. Nicol, B.J. Shelton, M.S. Knovich, et al. (2003) Overweight individuals are at increased risk for thrombotic thrombocytopenic purpura. Am J Hematol 74 170-174.
128. E.L. Amarosi and J.E. Ultmann (1966) Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature. Medicine 45 139-159.
129. C. Nabhan and H.C. Kwaan (2003) Current concepts in the diagnosis and management of thrombotic thrombocytopenic purpura. Hematol/Oncol Clin NA 17 177-199.
130. C.E. Thompson, L.E. Damon, C.A. Ries, et al. (1992) Thrombotic microangiopathies in the 1980s: Clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 80 1890-1895.
131. J.D. Cohen, M.E. Brechter and N. Bandarenko (1998) Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura. J Clin Apheresis 13 16-19.
132. J.S. Berns, B.S. Kaplan, R.C. Mackow, et al. (1992) Inherited hemolytic uremic syndrome in adults. Am J Kidney Dis, XIX 331-334.
133. F. Proulx, E.G. Siefdman and D. Karpman (2001) Pathogenesis of shiga toxin-associated hemolytic uremic syndrome. Ped Res 50 163-171.
134. C.M. Taylor (2001) Hemolytic uremic syndrome and complement factor H deficiency: Clinical aspects. Sem Thromb Hemost 27 185-190.
135. K.R. McCrae, J.E. Sadler, D.B. Cines (2005) Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. R. Hoffman, E.J. Benz, Jr.,S.J. Shattil, et al., (Eds) Hematology: Basic principles and practice Philadelphia: Elsevier, Churchill, Livingstone 2287-2304.
136. G. Neild (1987) The haemolytic uraemic syndrome: A review. Quart J Med 241 367-376.
137. A. Schieppati, P. Ruggenenti, C.R. Plata Cornejo R., et al. (1992) Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome. J Am Soc Nephrol 2 1640-1644.
138. J.N. George (2000) How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 96 1223-1229.
139. M.S. Esplin and D.W. Branch (1999) Diagnosis and management of thrombotic microangiopathies during pregnancy. Clin Obstet Gynecol 42 360-368.
140. M. Castella, M. Pujol, I. Massague, et al. (2004) Thrombotic thrombocytopenic purpura and pregancy: A review of ten cases. Vox Sang 87 287-290.
141. M. Furlan, R. Robles, M. Galbusera, et al. (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339 1578-1584.
142. H.-M. Tsai and E.C.Y. Lian (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339 1585-1594.
143. G.G. Levy, W.C. Nichols, E.C. Lian, et al. (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413 488-494.
144. V. Bianchi, R. Robles, L. Alberio, et al. (2002) von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: A severely deficient activity is specifi c for thrombotic thrombocytopenic purpura. Blood 100 710-713.
145. H.-M. Tsai (2003) Is severe deficiency of von Willebrand factor cleaving protease (ADAMTS-13) specific for thrombotic thrombocytopenic purpura? Yes. J Thromb Haemost 1 625-631.
146. P.M. Mannucci, M. Vanoli, I. Forza, et al. (2003) von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis). Haematologica 88 914-918.
147. P.M. Mannucci, T. Canciani, I. Forza, et al. (2001) Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 98 2730-2735.
148. A. Sanchez-Luceros, C.E. Farias, M.M. Amaral, et al. (2004) von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thromb Haemost 92 1320-1326.
149. J.L. Moake, J.J. Byrnes, J.H. Troll, et al. (1994) Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome. Blood 64 592-598.
150. J.L. Moake (2002) Thrombotic microangiopathies. N Engl J Med 347 589-600.
151. H.-M. Tsai (2005) Current concepts in thrombotic thrombocytopenic purpura. Ann Rev Med e-publication
152. J.N. George (2003) The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol 10 339-344.
153. R.A. Reiter, K. Varadi, P.L. Turecek, et al. (2005) Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation. Thromb Haemost 93 554-558.
154. A. Lattuada, E. Rossi, C. Calzarossa, et al. (2003) Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome. Haematologica 88 1029-1034.
155. C.P. Weiner (1987) Thrombotic microangiopathy in pregnancy and the postpartum period. Sem Hematol 24 119-129.
156. A. Proia, F. Paesano, L. Torcia, et al. (2002) Thrombotic thrombocytopenic purpura and pregnancy: A case report and a review of the literature. Ann Haematol 81 210-214.
157. A.S. Ducloy-Bouthors, C. Caron, D. Subtil, et al. (2003) Thrombotic thrombocytopenic purpura: Medical and biological monitoring of six pregnancies. Eur J Obstet Gynecol Repro Biol 111 146-152.
158. K. Clark (2004) TTP and me. The Practising Midwife 7 13-17.
159. D.M. Sherer, J. Sanmugarajah, M. Dalloul, et al. (2005) Thrombotic thrombocytopenic purpura in a patient with acquired immunodeficiency syndrome at 28 weeks gestation. Am J Perinatol 22 223-225.
160. S.L. Allford, B.J. Hunt, P. Rose, et al. (2003) Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology: Guidelines on the diagnosis and management of the thrombotic micro angiopathic haemolytic anaemias. Br J Haematol 120 556-573.
161. H.C. Kwaan and G.A. Soff (1997) Management of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Sem Hemato 34 159-166.
162. G.A. Rock, K.H. Shumak, N.A. Buskard, et al. (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325 393-397.
163. P. Ruggenenti and G. Remuzzi (1996) The pathophysiology and management of thrombotic thrombocytopenic purpura. Eur J Haematol 56 191-207.
164. G. Remuzzi (1995) The hemolytic uremic syndrome. Kidney Int 47 2-19.
165. S.K. Vesely, J.R. McMinn, D.R. Terrell, et al. (2004) Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 44 1149-1158.
166. M.F. Fesenmeir, K.H. Coppage, D.S. Lambers, et al. (2005) Acute fatty liver of pregnancy in three tertiary care centers. Am J Obstet Gynecol 192 1416-1419.
167. T.A. Knox and L.B. Olans (1996) Liver disease in pregnancy. N Engl J Med 335 569-576.
168. A.K. Burroughs, N.H. Seong, D.M. Dojcinov, et al. (1982) Idiopathic acute fatty liver of pregnancy in 12 patients. Quart J Med 51 481-497.
169. I.M. Usta, J.R. Barton, E.A. Amon, et al. (1994) Acute fatty liver of pregnancy: An experience in the diagnosis and managment of fourteen cases. Am J Obstet Gynecol 171 1342-1347.
170. J.A. Ibdah, Z. Yang and M.J. Bennett (2000) Liver disease in pregnancy and fetal fatty acid oxidation defects. Molec Genet Metab 71 182-187.
171. J.A. Ibdah, M.J. Bennett, P. Rinaldo, et al. (1999) A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 340 1723-1731.
172. M. Holub, O.A. Bodamer, C. Item, et al. (2005) Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome? Acta Paeds Scand 94 48-52.
173. A.C. Tan, J.H. van Krieken, W.H. Peters, et al. (2002) Acute fatty liver in pregnancy. Netherlands J Med 60 370-373.
174. M.A. Castro, T.M. Goodwin, K.J. Shaw, et al. (1996) Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy. Am J Obstet Gynecol 174 211-216.
175. D.L. Hepner and L.C. Tsen (2004) Severe thrombocytopenia, type 2B von Willebrand disease and pregnancy. Anesthesiol 101 1465-1467.
176. A. Casonato, M.T. Sartori, A. Bertomoro, et al. (1991) Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease. Blood Coag Fibrinol 2 33-40.
177. M. Icko, S. Sakurama, A. Sagawa, et al. (1990) Effect of a factor VIII concentrate on type IIB von Willebrand's disease-associated thrombocytopenia presenting during pregnancy in identical twin mothers. Am J Hematol 35 26-31.
178. M. Nardi and S. Karpatkin (2000) Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients. J Exp Med 191 2093-2100.
179. Z. Li, M.A. Nardi and S. Karpatkin (2005) Role of molecular mimicry to HIV-1 peptides in HIV-1 related immunologic thrombocytopenia. Blood 106 572-576.
180. C. Chelucci, M. Federico, R. Guerriero, et al. (1999) Productive human immunodeficiency virus-1 infection of puri-fied megakaryocytic progenitors/precursors and maturing megakaryocytes. Blood 91 1225-1234.
181. R. Diz-Kucukkaya, A. Hacehanefioglu, M. Yenerel, et al. (2001) Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: A prospective cohort study. Blood 98 1760-1764.
182. E.F. Chakravarty, I. Colon, E.S. Langen, et al. (2005) Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 192 1897-1904.
183. R.H. Aster (2005) Drug-induced immune cytopenias. Toxicology 209 149-153.
184. C.L. Balduini, A. Iolascon and A. Savoia (2002) Inherited thrombocytopenias. Haematologica 87 860-880.
185. M. Seri, R. Cusano, S. Gangarossa, et al. (2002) Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes: The May-Hegglin/Fechtner Syndrome Consortium. Nat Genet 26 103-105.
186. B.M. Sibai, M.K. Ramadan, R.S. Chari, et al. (1995) Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) : Subsequent pregnancy outcome and long term prognosis. Am J Obstet Gynecol 172 125-129.
187. C.A. Sullivan, E.F. Magann, K.G. Perry, et al. (1994) The recurrence risk of the syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP) in subsequent gestations. Am J Obstet Gynecol 171 940-943.
188. M.G. van Pampus, H. Wolf, G. Mayruu, et al. (2001) Long-term follow-up in patients with a history of (H) ELLP syndrome. Hypertens Preg 20 15-23.
189. M.C. Chames, B. Haddad, J.R. Barton, et al. (2003) Subsequent pregnancy outcome in women with a history of HELLP syndrome at 28 weeks of gestation. Am J Obstet Gynecol 188 1504-1508.